Proportion and Risk Indicators of Nonadherence to Statin Therapy: A Meta-analysis
Authors:
- Mark LemstraMLMark Lemstra
- David BlackburnDBDavid Blackburn
- Alex CrawleyACAlex Crawley
- Ryan FungRFRyan Fung
- 1 September 2012
- journal article
- research article
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 28 (5) , 574-580
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- The effect of cost on adherence to prescription medications in CanadaCanadian Medical Association Journal, 2012
- Predictors of Nonadherence to Statins: A Systematic Review and Meta-AnalysisAnnals of Pharmacotherapy, 2010
- Coronary heart disease in moderately hypercholesterolemic, hypertensive black and non-black patients randomized to pravastatin versus usual care: The Antihypertensive and Lipid Lowering to Prevent Heart Attack Trial (ALLHAT-LLT)American Heart Journal, 2009
- Cardiovascular and Economic Outcomes After Initiation of Lipid-Lowering Therapy With Atorvastatin vs Simvastatin in an Employed PopulationMayo Clinic Proceedings, 2009
- Associations of Kidney Function with Cardiovascular Medication Use after Myocardial InfarctionClinical Journal of the American Society of Nephrology, 2008
- Rationale and design of the Post-MI FREEE trial: A randomized evaluation of first-dollar drug coverage for post–myocardial infarction secondary preventive therapiesAmerican Heart Journal, 2008
- Adherence to statin or aspirin or both in patients with established cardiovascular disease: exploring healthy behaviour vs. drug effects and 10‐year follow‐up of outcomeBritish Journal of Clinical Pharmacology, 2008
- Impact of adherence to statins on coronary artery disease in primary preventionBritish Journal of Clinical Pharmacology, 2007
- Adherence to MedicationNew England Journal of Medicine, 2005
- Review papers : The statistical basis of meta-analysisStatistical Methods in Medical Research, 1993